- Home
- AVTX vs BRID Comparison
AVTX vs BRID Comparison
Compare AVTX & BRID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- BRID
- Stock Information
- Founded
- AVTX 2011
- BRID 1932
- Country
- AVTX United States
- BRID United States
- Employees
- AVTX N/A
- BRID N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- BRID Specialty Foods
- Sector
- AVTX Health Care
- BRID Consumer Staples
- Exchange
- AVTX Nasdaq
- BRID Nasdaq
- Market Cap
- AVTX 57.4M
- BRID 70.3M
- IPO Year
- AVTX 2015
- BRID N/A
- Fundamental
- Price
- AVTX $5.09
- BRID N/A
- Analyst Decision
- AVTX Strong Buy
- BRID
- Analyst Count
- AVTX 7
- BRID 0
- Target Price
- AVTX $31.00
- BRID N/A
- AVG Volume (30 Days)
- AVTX 122.3K
- BRID 5.5K
- Earning Date
- AVTX 08-11-2025
- BRID 08-22-2025
- Dividend Yield
- AVTX N/A
- BRID N/A
- EPS Growth
- AVTX N/A
- BRID N/A
- EPS
- AVTX N/A
- BRID N/A
- Revenue
- AVTX $441,000.00
- BRID $224,673,000.00
- Revenue This Year
- AVTX N/A
- BRID N/A
- Revenue Next Year
- AVTX N/A
- BRID N/A
- P/E Ratio
- AVTX $0.74
- BRID N/A
- Revenue Growth
- AVTX N/A
- BRID N/A
- 52 Week Low
- AVTX $3.39
- BRID $7.50
- 52 Week High
- AVTX $16.00
- BRID $14.69
- Technical
- Relative Strength Index (RSI)
- AVTX 57.49
- BRID 50.67
- Support Level
- AVTX $4.76
- BRID $7.78
- Resistance Level
- AVTX $5.05
- BRID $8.74
- Average True Range (ATR)
- AVTX 0.30
- BRID 0.22
- MACD
- AVTX 0.03
- BRID 0.01
- Stochastic Oscillator
- AVTX 84.75
- BRID 34.68
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About BRID Bridgford Foods Corporation
Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.